Using transgenic mice specifically lacking the PTEN gene in endothelial cells, Dr. Akira Suzuki and colleagues demonstrate that PTEN is required for normal cardiovascular development and that its loss enhanced tumor angiogenesis.
To be published in the September 1 issue of G&D, this new data suggests that PTEN regulates vascular growth factor (VGF) signaling to modulate cardiovascular development and post-natal neovascularization. Loss of PTEN in murine endothelial cells results is dysregulated VGF signaling, enhanced angiogenesis, and accelerated tumor growth.
Their results suggest that an individual who inherits a mutated PTEN allele, such as Cowden disease patient, is not only at risk for additional tumorigenic mutations, but may also experience accelerated growth of tumors due to enhanced angiogenesis. Moreover, the PTEN/PI3K pathway in endothelial cells is an attractive therapeutic target for the treatment of various malignancies.
Heather Cosel | Source: EurekAlert!
Further information: www.cshl.edu
More articles from Life Sciences:
First reconstitution of an epidermis from human embryonic stem cells
23.11.2009 | INSERM (Institut national de la santé et de la recherche médicale)
Causative gene of a rare disorder discovered by sequencing only protein-coding regions of genome
23.11.2009 | University of Washington
UCSB physicists move 1 step closer to quantum computing
23.11.2009 | Physics and Astronomy
Fat around the middle increases the risk of dementia
23.11.2009 | Studies and Analyses
New discovery about the formation of new brain cells
23.11.2009 | Health and Medicine
Multidisciplinary meeting on Urological Cancers aims to benefit cancer patients
20.11.2009 | Event News
'Golden Age' for clinical psychology in Northern Ireland
20.11.2009 | Event News
New Perspectives in Marine Anti-Fouling Research
11.11.2009 | Event News